Pinnacle Medicines

Private

Pioneer of oral peptide therapeutics that integrates physics-based molecular simulations, AI-enabled design, and advanced peptide chemistry. Pipeline targeting immunology and cardiometabolic diseases.

Founders Jonathan Wang

CEO Jonathan Wang

Company

Founded

2022

Headquarters

Doylestown, United States

Financials

Total Funding

$134M

Sectors

Artificial Intelligence Biotech

www.pinnaclemedicines.com

Funding History

2 rounds

Series B Mar 26, 2026

$89M

LAV (Lead) Foresite Capital Quan Capital Hankang Capital RA Capital Management Logos Capital OrbiMed

Series A Sep 1, 2023

$45M

OrbiMed

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.